Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Immunotherapy and targeted therapy combinations in metastatic breast cancer.

Esteva FJ, Hubbard-Lucey VM, Tang J, Pusztai L.

Lancet Oncol. 2019 Mar;20(3):e175-e186. doi: 10.1016/S1470-2045(19)30026-9. Review.

PMID:
30842061
2.

Trial watch: The clinical trial landscape for PD1/PDL1 immune checkpoint inhibitors.

Tang J, Yu JX, Hubbard-Lucey VM, Neftelinov ST, Hodge JP, Lin Y.

Nat Rev Drug Discov. 2018 Nov 28;17(12):854-855. doi: 10.1038/nrd.2018.210. No abstract available.

PMID:
30482962
3.

Trends in the global immuno-oncology landscape.

Tang J, Pearce L, O'Donnell-Tormey J, Hubbard-Lucey VM.

Nat Rev Drug Discov. 2018 Dec;17(12):922. doi: 10.1038/nrd.2018.202. Epub 2018 Oct 26.

PMID:
30361553
4.

Trends in the global immuno-oncology landscape.

Tang J, Pearce L, O'Donnell-Tormey J, Hubbard-Lucey VM.

Nat Rev Drug Discov. 2018 Nov;17(11):783-784. doi: 10.1038/nrd.2018.167. Epub 2018 Oct 19. No abstract available. Erratum in: Nat Rev Drug Discov. 2018 Oct 26;:.

PMID:
30337722
5.

The global landscape of cancer cell therapy.

Tang J, Hubbard-Lucey VM, Pearce L, O'Donnell-Tormey J, Shalabi A.

Nat Rev Drug Discov. 2018 Jul;17(7):465-466. doi: 10.1038/nrd.2018.74. Epub 2018 May 25. No abstract available.

PMID:
29795477
6.

Comprehensive analysis of the clinical immuno-oncology landscape.

Tang J, Shalabi A, Hubbard-Lucey VM.

Ann Oncol. 2018 Jan 1;29(1):84-91. doi: 10.1093/annonc/mdx755. Review.

PMID:
29228097
7.

Autophagy protein ATG16L1 prevents necroptosis in the intestinal epithelium.

Matsuzawa-Ishimoto Y, Shono Y, Gomez LE, Hubbard-Lucey VM, Cammer M, Neil J, Dewan MZ, Lieberman SR, Lazrak A, Marinis JM, Beal A, Harris PA, Bertin J, Liu C, Ding Y, van den Brink MRM, Cadwell K.

J Exp Med. 2017 Dec 4;214(12):3687-3705. doi: 10.1084/jem.20170558. Epub 2017 Oct 31.

8.

A Blueprint to Advance Colorectal Cancer Immunotherapies.

Le DT, Hubbard-Lucey VM, Morse MA, Heery CR, Dwyer A, Marsilje TH, Brodsky AN, Chan E, Deming DA, Diaz LA Jr, Fridman WH, Goldberg RM, Hamilton SR, Housseau F, Jaffee EM, Kang SP, Krishnamurthi SS, Lieu CH, Messersmith W, Sears CL, Segal NH, Yang A, Moss RA, Cha E, O'Donnell-Tormey J, Roach N, Davis AQ, McAbee K, Worrall S, Benson AB.

Cancer Immunol Res. 2017 Nov;5(11):942-949. doi: 10.1158/2326-6066.CIR-17-0375. Epub 2017 Oct 16.

9.

Translating Science into Survival: Report on the Second International Cancer Immunotherapy Conference.

Brodsky AN, Hubbard-Lucey VM.

Cancer Immunol Res. 2016 Dec;4(12):996-1000.

10.
11.

De-Risking Immunotherapy: Report of a Consensus Workshop of the Cancer Immunotherapy Consortium of the Cancer Research Institute.

Mellman I, Hubbard-Lucey VM, Tontonoz MJ, Kalos MD, Chen DS, Allison JP, Drake CG, Levitsky H, Lonberg N, van der Burg SH, Fearon DT, Wherry EJ, Lowy I, Vonderheide RH, Hwu P.

Cancer Immunol Res. 2016 Apr;4(4):279-88. doi: 10.1158/2326-6066.CIR-16-0045. Review.

12.

Autophagy gene Atg16L1 prevents lethal T cell alloreactivity mediated by dendritic cells.

Hubbard-Lucey VM, Shono Y, Maurer K, West ML, Singer NV, Ziegler CG, Lezcano C, Motta AC, Schmid K, Levi SM, Murphy GF, Liu C, Winkler JD, Amaravadi RK, Rogler G, Dickinson AM, Holler E, van den Brink MR, Cadwell K.

Immunity. 2014 Oct 16;41(4):579-91. doi: 10.1016/j.immuni.2014.09.011. Epub 2014 Oct 9.

13.

Enhanced responses to tumor immunization following total body irradiation are time-dependent.

Diab A, Jenq RR, Rizzuto GA, Cohen AD, Huggins DW, Merghoub T, Engelhorn ME, Guevara-Patiño JA, Suh D, Hubbard-Lucey VM, Kochman AA, Chen S, Zhong H, Wolchok JD, van den Brink MR, Houghton AN, Perales MA.

PLoS One. 2013 Dec 12;8(12):e82496. doi: 10.1371/journal.pone.0082496. eCollection 2013.

14.

A deficiency in the autophagy gene Atg16L1 enhances resistance to enteric bacterial infection.

Marchiando AM, Ramanan D, Ding Y, Gomez LE, Hubbard-Lucey VM, Maurer K, Wang C, Ziel JW, van Rooijen N, Nuñez G, Finlay BB, Mysorekar IU, Cadwell K.

Cell Host Microbe. 2013 Aug 14;14(2):216-24. doi: 10.1016/j.chom.2013.07.013.

Supplemental Content

Loading ...
Support Center